Schedule An Interview
Schedule A Remote Interview with OncologyTube
0
Title
User
LIVE NOW
LIVE NOW
Title
User
Home
Trending
Sign In
Audios and Videos
Videos
Audios
Channels
Browse Channels
Categories
Acute Lymphoblastic Leukemia
5639
Acute Myelogenous Leukemia
191
Bladder Cancer
61
Bone Metastases
1
Brain Cancer
34
Breast Cancer
199
Business Management
3
Cervical Cancer
3
Chronic Lymphocytic Leukemia
181
Chronic Myelogenous Leukemia
36
Colorectal Cancer
84
COVID-19
21
Gastrointestinal Cancer
76
General
253
Head and Neck Cancers
42
Hematologic Malignancies
176
Hodgkin Lymphoma
19
Immunotherapy
129
Kidney Cancer
366
Liver Cancer
15
Lymphoma
153
Melanoma and Skin Cancer
52
Multiple Myeloma
425
Myeloproliferative Disease
18
News
144
Non-Hodgkin Lymphoma
73
Non-Small Cell Lung Cancer
335
Other
208
Ovarian Cancer
18
Pancreatic Cancer
65
Patient Resources
28
Pediatric Cancer
4
Prostate Cancer
204
Sickle Cell
17
Small Cell Lung Cancer
63
Soft Tissue Sarcoma
9
Supportive Care
47
Testicular Cancer
2
Urology
12
Uterine Cancer
2
About
Contact
00:01:03
Design of the RECOURSE trial on which the FDA approved TAS-102
Axel Grothey, MD of Mayo Clinic discusses the design of the RECOURSE trial on which the FDA approved TAS-102 at ASCO GI 2016
Acute Lymphoblastic Leukemia
404 Views
4 years ago
Gastrointestinal-Cancer-Meeting
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
Live
Suggested
Trending
00:01:10
Understanding Biology With ADAPTeR Study
Kidney Cancer
Free
85 Views
1 year ago
kidneycancer
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
Precigen Announces First Patient Dosed in Phase 1 Study of PRGN-3005 UltraCAR-T in Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Acute Lymphoblastic Leukemia
Free
136 Views
11 months ago
Annual-Meeting
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:03:03
Smoldering Myeloma ECOG Trial: Patients With Intermediate & High Risk MM Had An Improved Time To Progression Compared To Those Being Observed
Multiple Myeloma
Free
223 Views
1 year ago
Annual-Meeting
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:29:26
Immunotherapy - Small Cell Lung Cancer Virtual Roundtable
Small Cell Lung Cancer
Free
598 Views
2 years ago
Cancer-Roundtables
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
Latest Videos
0:00:57
Timothy A Yap, MD, PhD on AVID200: Why Should TGF-beta 1 and 3 Be Targeted? @MDAndersonNews
Other
Free
3 Views
9 hours ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:02:11
Timothy A Yap, MD, PhD on AVID200: TGF-beta 1 and 3 @MDAndersonNews
Other
Free
1 Views
9 hours ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:05:21
Matthew P. Goetz, MD on Genomic Alterations in Circulating Tumor DNA @MayoClinic
Other
Free
1 Views
9 hours ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:03:54
Marwan Fakih, MD on Regorafenib and Nivolumab: Different Responses
Colorectal Cancer
Free
1 Views
17 hours ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
